Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

18.27
-0.2500-1.35%
Volume:159.18K
Turnover:2.90M
Market Cap:1.01B
PE:-13.36
High:18.82
Open:18.75
Low:17.93
Close:18.52
52wk High:34.19
52wk Low:14.72
Shares:55.28M
Float Shares:17.65M
Volume Ratio:0.92
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3680
EPS(LYR):-78.3394
ROE:-29.45%
ROA:-15.79%
PB:2.08
PE(LYR):-0.23

Loading ...

OverviewCompanyNewsFilings

Aktis Oncology Initiates Phase 1B Clinical Trial for Aky-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

THOMSON REUTERS
·
May 05

Aktis Oncology Initiated at Outperform by William Blair

Dow Jones
·
Apr 29

William Blair Initiates Aktis Oncology at Outperform

MT Newswires Live
·
Apr 29

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire
·
Apr 22

Aktis Oncology Board Shift And New Committee Draw Investor Focus On R&D

Simply Wall St.
·
Apr 19

Aktis Oncology director Glenn Gormley files initial beneficial ownership statement

Reuters
·
Apr 17

Aktis Oncology appoints Gormley as independent director of Board of Directors

TIPRANKS
·
Apr 16

Press Release: Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

Dow Jones
·
Apr 16

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 13, 2026 Post-Mkt
Financial Report Announcement
May 11, 2026 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-13.36
Current
-6.27
Sector Average
17.99%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-13.36
Maximum
-0.05
+1 STD
0.79
Minimum
-26.75
-1 STD
-13.33
Average
-6.27

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.